Previous Article | Next Article 
Journal of Virology, September 2002, p. 9096-9102, Vol. 76, No. 18
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.18.9096-9102.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Effect of Altering the tRNA
Concentration in Human Immunodeficiency Virus Type 1 upon Its Annealing to Viral RNA, GagPol Incorporation, and Viral Infectivity
Juliana Gabor,1,2 Shan Cen,1 Hassan Javanbakht,1,3 Meijuan Niu,1 and Lawrence Kleiman1,2,3*
Lady Davis Institute for Medical Research and McGill AIDS Centre, Jewish General Hospital,1
Departments of Medicine,3
Microbiology and Immunology, McGill University, Montreal, H3T 1E2 Quebec, Canada2
Received 19 February 2002/
Accepted 4 May 2002
Human immunodeficiency virus type 1 (HIV-1) uses tRNA
as a primer for reverse transcription and, during viral assembly, this tRNA is selectively packaged into the virus along with the other major tRNALys, tRNA
. Increasing the cytoplasmic concentration of tRNA
through transfection of cells with a plasmid containing both HIV-1 proviral DNA and a tRNA
gene results in a greater incorporation of tRNA
into virions, which is accompanied by increased annealing of tRNA
to the viral genome and increased infectivity of the viral population. Increased viral tRNA
is accompanied by decreased viral tRNA
, with the total tRNALys/virion and the GagPol/Gag ratios remaining unchanged. Viral tRNALys can be doubled, with increases in both tRNA
and tRNA
concentrations, by overexpressing lysyl tRNA synthetase. This also results in increased tRNA
annealing to the viral RNA and increased viral infectivity but, again, no change in the GagPol/Gag ratio was observed. This result indicates that GagPol, whose interaction is required during packaging, is not a limiting factor during tRNALys incorporation into HIV-1, whereas LysRS is.
* Corresponding author. Mailing address: Lady Davis Institute for Medical Research-Jewish General Hospital, 3755 Cote St. Catherine Rd., Montreal, H3T 1E2 Quebec, Canada. Phone: (514) 340-8260. Fax: (514) 340-7502. E-mail:
lawrence.kleiman{at}mcgill.ca.
Journal of Virology, September 2002, p. 9096-9102, Vol. 76, No. 18
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.18.9096-9102.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Guo, F., Saadatmand, J., Niu, M., Kleiman, L.
(2009). Roles of Gag and NCp7 in Facilitating Formula Annealing to Viral RNA in Human Immunodeficiency Virus Type 1. J. Virol.
83: 8099-8107
[Abstract]
[Full Text]
-
Bilbille, Y., Vendeix, F. A. P., Guenther, R., Malkiewicz, A., Ariza, X., Vilarrasa, J., Agris, P. F.
(2009). The structure of the human tRNALys3 anticodon bound to the HIV genome is stabilized by modified nucleosides and adjacent mismatch base pairs. Nucleic Acids Res
37: 3342-3353
[Abstract]
[Full Text]
-
Wei, M., Yang, Y., Niu, M., Desfosse, L., Kennedy, R., Musier-Forsyth, K., Kleiman, L.
(2008). Inability of Human Immunodeficiency Virus Type 1 Produced in Murine Cells To Selectively Incorporate Primer Formula. J. Virol.
82: 12049-12059
[Abstract]
[Full Text]
-
Li, X.-Y., Guo, F., Zhang, L., Kleiman, L., Cen, S.
(2007). APOBEC3G Inhibits DNA Strand Transfer during HIV-1 Reverse Transcription. J. Biol. Chem.
282: 32065-32074
[Abstract]
[Full Text]
-
Guo, F., Cen, S., Niu, M., Saadatmand, J., Kleiman, L.
(2006). Inhibition of Formula-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication. J. Virol.
80: 11710-11722
[Abstract]
[Full Text]
-
Wei, M., Cen, S., Niu, M., Guo, F., Kleiman, L.
(2005). Defective Replication in Human Immunodeficiency Virus Type 1 When Non-Primers Are Used for Reverse Transcription. J. Virol.
79: 9081-9087
[Abstract]
[Full Text]
-
Guo, F., Gabor, J., Cen, S., Hu, K., Mouland, A. J., Kleiman, L.
(2005). Inhibition of Cellular HIV-1 Protease Activity by Lysyl-tRNA Synthetase. J. Biol. Chem.
280: 26018-26023
[Abstract]
[Full Text]
-
Goldschmidt, V., Paillart, J.-C., Rigourd, M., Ehresmann, B., Aubertin, A.-M., Ehresmann, C., Marquet, R.
(2004). Structural Variability of the Initiation Complex of HIV-1 Reverse Transcription. J. Biol. Chem.
279: 35923-35931
[Abstract]
[Full Text]
-
Halwani, R., Cen, S., Javanbakht, H., Saadatmand, J., Kim, S., Shiba, K., Kleiman, L.
(2004). Cellular Distribution of Lysyl-tRNA Synthetase and Its Interaction with Gag during Human Immunodeficiency Virus Type 1 Assembly. J. Virol.
78: 7553-7564
[Abstract]
[Full Text]
-
Cen, S., Javanbakht, H., Niu, M., Kleiman, L.
(2004). Ability of Wild-Type and Mutant Lysyl-tRNA Synthetase To Facilitate tRNALys Incorporation into Human Immunodeficiency Virus Type 1. J. Virol.
78: 1595-1601
[Abstract]
[Full Text]
-
Cen, S., Niu, M., Saadatmand, J., Guo, F., Huang, Y., Nabel, G. J., Kleiman, L.
(2004). Incorporation of Pol into Human Immunodeficiency Virus Type 1 Gag Virus-Like Particles Occurs Independently of the Upstream Gag Domain in Gag-Pol. J. Virol.
78: 1042-1049
[Abstract]
[Full Text]
-
Guo, F., Cen, S., Niu, M., Javanbakht, H., Kleiman, L.
(2003). Specific Inhibition of the Synthesis of Human Lysyl-tRNA Synthetase Results in Decreases in tRNALys Incorporation, tRNA3LysAnnealing to Viral RNA, and Viral Infectivity in Human Immunodeficiency Virus Type 1. J. Virol.
77: 9817-9822
[Abstract]
[Full Text]
-
Javanbakht, H., Halwani, R., Cen, S., Saadatmand, J., Musier-Forsyth, K., Gottlinger, H., Kleiman, L.
(2003). The Interaction between HIV-1 Gag and Human Lysyl-tRNA Synthetase during Viral Assembly. J. Biol. Chem.
278: 27644-27651
[Abstract]
[Full Text]
-
Cen, S., Javanbakht, H., Kim, S., Shiba, K., Craven, R., Rein, A., Ewalt, K., Schimmel, P., Musier-Forsyth, K., Kleiman, L.
(2002). Retrovirus-Specific Packaging of Aminoacyl-tRNA Synthetases with Cognate Primer tRNAs. J. Virol.
76: 13111-13115
[Abstract]
[Full Text]